Background: Segregation is used increasingly to prevent cross infection, yet little is known about service users' views regarding segregation and its perceived impact. The aim of this study was to elicit patients and carers' views and to involve them in the process of introducing segregation in a paediatric CF centre.
Method: Open-ended questionnaires were posted to all parents (n=192) and to patients over 10 years (n=101). A content analysis identified common themes. Inter-rater agreement about themes was high (83%).
Results: Parents (91%) and children (92%) supported segregated treatment. Parents appeared to be aware of the positive and negative aspects of segregation, and to engage in a balancing act that led them to conclude that segregation was a 'necessary evil'. Children appeared to be less analytical and were concerned mostly with boredom and isolation. Age, level of maturity, and hospital experience were perceived to be determinants of patient adaptation to segregation.
Conclusion: Segregation has considerable emotional, social, and practical implications for patients and families. Obtaining users' views increased our understanding of the psychosocial consequences of segregation and facilitated its implementation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jcf.2005.12.002 | DOI Listing |
Front Med (Lausanne)
January 2025
Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
Introduction: The 2020 pharmaceutical strategy for Europe stressed that rethinking regulatory policies to foster innovation in disease areas with unmet medical needs (UMN) is one of the European Commission's (EC) priority areas. To understand stakeholders' views regarding appropriate UMN criteria and incentives, the EC developed a survey and launched it for public consultation between September and December 2021. This study aims to assess stakeholders' views on the policy revisions proposed by the EC, particularly those regarding the definition of UMN, its criteria and incentives and evaluate how stakeholders' views are reflected in the proposed reform of the EU pharmaceutical legislation of 2023.
View Article and Find Full Text PDFBMC Med
January 2025
Nuffield Department of Primary Care Health Sciences, University of Oxford, Radcliffe Observatory Quarter, Woodstock Road, Oxford, OX2 6GG, UK.
Background: The NHS App launched in 2019 as the 'digital front door' to the National Health Service in England with core features including General Practitioner (GP) appointment booking, repeat prescriptions, patient access to records and, later on, COVID-19 vaccination certification. Similar patient portals have been adopted in different formats and with variable levels of success. In this longitudinal study (2021-2023) we examined how the NHS App became implemented in the pandemic context and beyond.
View Article and Find Full Text PDFClin Cardiol
January 2025
Tehran Heart Center, Cardiovascular Disease Research Institute, Tehran University of Medical Sciences (TUMS), Tehran, Iran.
Background: Hypertension, a leading global risk factor for mortality and disability, disproportionately affects racial and ethnic minorities. Our study investigates the association between the type of prior antihypertensive medication use and the likelihood of cardiovascular events (CVE) and assesses whether the patient's race influences this relationship.
Methods: A retrospective study of 14 836 hypertension cases aged ≥ 40 years was conducted using data from HCA Healthcare between 2017 and 2023.
BMC Nurs
January 2025
Department of Nursing, Catholic University of Croatia, Ilica 244, Zagreb, Croatia.
Background: Evidence shows harmful effects of e-cigarettes on health. There is limited data on the use of e-cigarettes among nursing students. This study aimed to investigate the usage, knowledge, and attitudes towards e-cigarettes among nursing students in Croatia, as well as their views on the role of nurses in counseling patients and assisting with smoking cessation.
View Article and Find Full Text PDFTob Prev Cessat
January 2025
School of Public Health, Bielefeld University, Bielefeld, Germany.
Introduction: The tobacco industry presence in the retail environment ensures its access to current and potential tobacco users. Reduction of tobacco retail is an emerging tobacco control measure. Many policies that would potentially lead to reduction in retail are not covered by international tobacco laws and are individually adopted in some jurisdictions.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!